Pfizer Inc vs Snap Inc — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Snap Inc trades at $4.48 (market cap $7.67B). The key difference: Pfizer Inc is far larger — about 18.5× Snap Inc's market cap, and Pfizer Inc pays a 6.9% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| PFE | SNAP | |
|---|---|---|
Market Cap | $142.14B | $7.67B |
Volume | 29,869,932 | — |
Sector | Health | Media |
52-Week High | $28.56 | $10.35 |
52-Week Low | $23.29 | $3.93 |
Enterprise Value | $192.80B | $9.05B |
Dividend Yield | 6.9% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →